Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Argilés À[au]:

Normal and pathologic concentrations of uremic toxins. Duranton F et al. J Am Soc Nephrol. (2012)

Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis. Siwy J et al. Nephrol Dial Transplant. (2017)

Is Plasma Proteomics Able to Provide Alternative Paths to Better Understand Hypertension? Argilés À et al. Hypertension. (2017)

Search results

Items: 1 to 50 of 131

1.

Blood Pressure Seasonality in Hemodialysis Patients from Five European Cities of Different Latitudes.

Duranton F, Palma A, Stegmayr B, Wauthier M, Torres A, Argilés À.

Kidney Blood Press Res. 2018;43(5):1529-1538. doi: 10.1159/000494019. Epub 2018 Oct 4.

2.

The CKD plasma lipidome varies with disease severity and outcome.

Duranton F, Laget J, Gayrard N, Saulnier-Blache JS, Lundin U, Schanstra JP, Mischak H, Weinberger KM, Servel MF, Argilés A.

J Clin Lipidol. 2019 Jan - Feb;13(1):176-185.e8. doi: 10.1016/j.jacl.2018.07.010. Epub 2018 Aug 1.

PMID:
30177483
3.

Correction: Consequences of increasing convection onto patient care and protein removal in hemodialysis.

Gayrard N, Ficheux A, Duranton F, Guzman C, Szwarc I, Vetromile F, Cazevieille C, Brunet P, Servel MF, Argilés À, Le Quintrec M.

PLoS One. 2018 Jan 2;13(1):e0190761. doi: 10.1371/journal.pone.0190761. eCollection 2018.

4.

Geographical Variations in Blood Pressure Level and Seasonality in Hemodialysis Patients.

Duranton F, Kramer A, Szwarc I, Bieber B, Gayrard N, Jover B, Vetromile F, Massy ZA, Combe C, Tentori F, Jager KJ, Servel MF, Argilés À.

Hypertension. 2018 Feb;71(2):289-296. doi: 10.1161/HYPERTENSIONAHA.117.10274. Epub 2017 Dec 18.

PMID:
29255071
5.

Is Plasma Proteomics Able to Provide Alternative Paths to Better Understand Hypertension?

Argilés À, Rodriguez M, Ortiz A.

Hypertension. 2017 Aug;70(2):250-252. doi: 10.1161/HYPERTENSIONAHA.117.09049. Epub 2017 Jun 26. No abstract available.

PMID:
28652468
6.

Clinical expectations for the new bioactive treatments: greater well-being or longer survival?

Szwarc I, Vetromile F, Buscaroli A, Françoise Servel M, Argilés À.

Int J Artif Organs. 2017 Jul 5;40(7):335-337. doi: 10.5301/ijao.5000582. Epub 2017 Jun 14. No abstract available.

PMID:
28623641
7.

A reliable method to assess the water permeability of a dialysis system: the global ultrafiltration coefficient.

Ficheux A, Gayrard N, Duranton F, Guzman C, Szwarc I, Vetromile F, Brunet P, Servel MF, Argilés A.

Nephrol Dial Transplant. 2017 Feb 1;32(2):364-370. doi: 10.1093/ndt/gfw370.

8.

Consequences of increasing convection onto patient care and protein removal in hemodialysis.

Gayrard N, Ficheux A, Duranton F, Guzman C, Szwarc I, Vetromile F, Cazevieille C, Brunet P, Servel MF, Argilés À, Le Quintrec M.

PLoS One. 2017 Feb 6;12(2):e0171179. doi: 10.1371/journal.pone.0171179. eCollection 2017. Erratum in: PLoS One. 2018 Jan 2;13(1):e0190761.

9.

Primary sclerosing cholangitis: a new cause of distal renal tubular acidosis.

Goutaudier V, Szwarc I, Serre JE, Pageaux GP, Argilés À, Ribstein J.

Clin Kidney J. 2016 Dec;9(6):811-813. Epub 2016 Aug 31.

10.

Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis.

Siwy J, Zürbig P, Argiles A, Beige J, Haubitz M, Jankowski J, Julian BA, Linde PG, Marx D, Mischak H, Mullen W, Novak J, Ortiz A, Persson F, Pontillo C, Rossing P, Rupprecht H, Schanstra JP, Vlahou A, Vanholder R.

Nephrol Dial Transplant. 2017 Dec 1;32(12):2079-2089. doi: 10.1093/ndt/gfw337.

11.

Early changes in body weight and blood pressure are associated with mortality in incident dialysis patients.

Duranton F, Duny Y, Szwarc I, Deleuze S, Rouanet C, Selcer I, Maurice F, Rivory JP, Servel MF, Jover B, Brunet P, Daurès JP, Argilés À.

Clin Kidney J. 2016 Apr;9(2):287-94. doi: 10.1093/ckj/sfv153. Epub 2016 Jan 29.

12.

On the discovery of UREA. Identification, synthesis and observations that let to establishing the first uraemic retention solute.

Duranton F, Jankowski J, Więcek A, Argilés À.

G Ital Nefrol. 2016 Feb;33 Suppl 66:33.S66.16.

13.

The fate of triaged and rejected manuscripts.

Zoccali C, Amodeo D, Argiles A, Arici M, D'arrigo G, Evenepoel P, Fliser D, Fox J, Gesualdo L, Jadoul M, Ketteler M, Malyszko J, Massy Z, Mayer G, Ortiz A, Sever M, Vanholder R, Vinck C, Wanner C, Więcek A.

Nephrol Dial Transplant. 2015 Dec;30(12):1947-50. doi: 10.1093/ndt/gfv387.

14.

New insights in molecular mechanisms involved in chronic kidney disease using high-resolution plasma proteome analysis.

Glorieux G, Mullen W, Duranton F, Filip S, Gayrard N, Husi H, Schepers E, Neirynck N, Schanstra JP, Jankowski J, Mischak H, Argilés À, Vanholder R, Vlahou A, Klein J.

Nephrol Dial Transplant. 2015 Nov;30(11):1842-52. doi: 10.1093/ndt/gfv254. Epub 2015 Jul 9.

PMID:
26160894
15.

Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides.

Schanstra JP, Zürbig P, Alkhalaf A, Argiles A, Bakker SJ, Beige J, Bilo HJ, Chatzikyrkou C, Dakna M, Dawson J, Delles C, Haller H, Haubitz M, Husi H, Jankowski J, Jerums G, Kleefstra N, Kuznetsova T, Maahs DM, Menne J, Mullen W, Ortiz A, Persson F, Rossing P, Ruggenenti P, Rychlik I, Serra AL, Siwy J, Snell-Bergeon J, Spasovski G, Staessen JA, Vlahou A, Mischak H, Vanholder R.

J Am Soc Nephrol. 2015 Aug;26(8):1999-2010. doi: 10.1681/ASN.2014050423. Epub 2015 Jan 14.

16.

[Preventing chronic kidney disease in France: advantages, feasibility and concerns].

Duranton F, Brunet P, Laville M, Landais P, Daurès JP, Mourad G, Bustins M, Argilés A.

Nephrol Ther. 2014 Dec;10(7):492-9. doi: 10.1016/j.nephro.2014.06.007. Epub 2014 Nov 20. Review. French.

PMID:
25457993
17.

Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease.

Nkuipou-Kenfack E, Duranton F, Gayrard N, Argilés À, Lundin U, Weinberger KM, Dakna M, Delles C, Mullen W, Husi H, Klein J, Koeck T, Zürbig P, Mischak H.

PLoS One. 2014 May 9;9(5):e96955. doi: 10.1371/journal.pone.0096955. eCollection 2014.

18.

Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.

Siwy J, Schanstra JP, Argiles A, Bakker SJ, Beige J, Boucek P, Brand K, Delles C, Duranton F, Fernandez-Fernandez B, Jankowski ML, Al Khatib M, Kunt T, Lajer M, Lichtinghagen R, Lindhardt M, Maahs DM, Mischak H, Mullen W, Navis G, Noutsou M, Ortiz A, Persson F, Petrie JR, Roob JM, Rossing P, Ruggenenti P, Rychlik I, Serra AL, Snell-Bergeon J, Spasovski G, Stojceva-Taneva O, Trillini M, von der Leyen H, Winklhofer-Roob BM, Zürbig P, Jankowski J.

Nephrol Dial Transplant. 2014 Aug;29(8):1563-70. doi: 10.1093/ndt/gfu039. Epub 2014 Mar 2.

19.

The Saga of Two Centuries of Urea: Nontoxic Toxin or Vice Versa?

Duranton F, Depner TA, Argilés À.

Semin Nephrol. 2014 Mar;34(2):87-96. doi: 10.1016/j.semnephrol.2014.02.002. Epub 2014 Feb 15. Review.

PMID:
26248717
20.

The ultrafiltration coefficient: this old 'grand inconnu' in dialysis.

Ficheux A, Ronco C, Brunet P, Argilés À.

Nephrol Dial Transplant. 2015 Feb;30(2):204-8. doi: 10.1093/ndt/gft493. Epub 2013 Dec 19. Review. No abstract available.

21.

Plasma and urinary amino acid metabolomic profiling in patients with different levels of kidney function.

Duranton F, Lundin U, Gayrard N, Mischak H, Aparicio M, Mourad G, Daurès JP, Weinberger KM, Argilés A.

Clin J Am Soc Nephrol. 2014 Jan;9(1):37-45. doi: 10.2215/CJN.06000613. Epub 2013 Nov 14.

22.

Exogenous thyrotropin improves renal function in euthyroid patients, while serum creatinine levels are increased in hypothyroidism.

Duranton F, Lacoste A, Faurous P, Deshayes E, Ribstein J, Avignon A, Mourad G, Argilés À.

Clin Kidney J. 2013 Oct;6(5):478-83. doi: 10.1093/ckj/sft092. Epub 2013 Sep 1.

23.

CKD273, a new proteomics classifier assessing CKD and its prognosis.

Argilés Á, Siwy J, Duranton F, Gayrard N, Dakna M, Lundin U, Osaba L, Delles C, Mourad G, Weinberger KM, Mischak H.

PLoS One. 2013 May 14;8(5):e62837. doi: 10.1371/journal.pone.0062837. Print 2013.

24.

Vitamin D treatment and mortality in chronic kidney disease: a systematic review and meta-analysis.

Duranton F, Rodriguez-Ortiz ME, Duny Y, Rodriguez M, Daurès JP, Argilés A.

Am J Nephrol. 2013;37(3):239-48. doi: 10.1159/000346846. Epub 2013 Mar 5. Review.

25.

Normal and pathologic concentrations of uremic toxins.

Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, Argiles A; European Uremic Toxin Work Group.

J Am Soc Nephrol. 2012 Jul;23(7):1258-70. doi: 10.1681/ASN.2011121175. Epub 2012 May 24. Review. Erratum in: J Am Soc Nephrol. 2013 Dec;24(12):2127-9.

26.

Implementation of proteomic biomarkers: making it work.

Mischak H, Ioannidis JP, Argiles A, Attwood TK, Bongcam-Rudloff E, Broenstrup M, Charonis A, Chrousos GP, Delles C, Dominiczak A, Dylag T, Ehrich J, Egido J, Findeisen P, Jankowski J, Johnson RW, Julien BA, Lankisch T, Leung HY, Maahs D, Magni F, Manns MP, Manolis E, Mayer G, Navis G, Novak J, Ortiz A, Persson F, Peter K, Riese HH, Rossing P, Sattar N, Spasovski G, Thongboonkerd V, Vanholder R, Schanstra JP, Vlahou A.

Eur J Clin Invest. 2012 Sep;42(9):1027-36. doi: 10.1111/j.1365-2362.2012.02674.x. Epub 2012 Apr 21.

27.

Determination of uremic solutes in biological fluids of chronic kidney disease patients by HPLC assay.

Calaf R, Cerini C, Génovésio C, Verhaeghe P, Jourde-Chiche N, Bergé-Lefranc D, Gondouin B, Dou L, Morange S, Argilés A, Rathelot P, Dignat-George F, Brunet P, Charpiot P.

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Aug 1;879(23):2281-6. doi: 10.1016/j.jchromb.2011.06.014. Epub 2011 Jun 15.

PMID:
21727042
28.

Does uremia cause vascular dysfunction?

Brunet P, Gondouin B, Duval-Sabatier A, Dou L, Cerini C, Dignat-George F, Jourde-Chiche N, Argiles A, Burtey S.

Kidney Blood Press Res. 2011;34(4):284-90. doi: 10.1159/000327131. Epub 2011 Jun 21. Review.

29.

The use of SDS-PAGE scanning of spent dialysate to assess uraemic toxin removal by dialysis.

Ficheux A, Gayrard N, Szwarc I, Andress D, Soullier S, Duny Y, Goubert G, Thomas M, Bismuth-Mondolfo J, Daurès JP, Brunet P, Servel MF, Argilés A.

Nephrol Dial Transplant. 2011 Jul;26(7):2281-9. doi: 10.1093/ndt/gfq709. Epub 2010 Dec 10.

30.

Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in vitro evaluation.

Schepers E, Glorieux G, Dou L, Cerini C, Gayrard N, Louvet L, Maugard C, Preus P, Rodriguez-Ortiz M, Argiles A, Brunet P, Cohen G, Jankowski J, Jankowski V, Massy Z, Rodriguez M, Vanholder R; European Uremic Toxin Work Group (EUTox).

Blood Purif. 2010;30(4):277-87. doi: 10.1159/000320765. Epub 2010 Nov 16.

31.

Urinary collagen fragments are significantly altered in diabetes: a link to pathophysiology.

Maahs DM, Siwy J, Argilés A, Cerna M, Delles C, Dominiczak AF, Gayrard N, Iphöfer A, Jänsch L, Jerums G, Medek K, Mischak H, Navis GJ, Roob JM, Rossing K, Rossing P, Rychlík I, Schiffer E, Schmieder RE, Wascher TC, Winklhofer-Roob BM, Zimmerli LU, Zürbig P, Snell-Bergeon JK.

PLoS One. 2010 Sep 28;5(9). pii: e13051. doi: 10.1371/journal.pone.0013051.

32.

The ultrafiltration coefficient of a dialyser (KUF) is not a fixed value, and it follows a parabolic function: the new concept of KUF max.

Ficheux A, Kerr PG, Brunet P, Argilés À.

Nephrol Dial Transplant. 2011 Feb;26(2):636-40. doi: 10.1093/ndt/gfq510. Epub 2010 Sep 8.

PMID:
20826740
33.

Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.

Good DM, Zürbig P, Argilés A, Bauer HW, Behrens G, Coon JJ, Dakna M, Decramer S, Delles C, Dominiczak AF, Ehrich JH, Eitner F, Fliser D, Frommberger M, Ganser A, Girolami MA, Golovko I, Gwinner W, Haubitz M, Herget-Rosenthal S, Jankowski J, Jahn H, Jerums G, Julian BA, Kellmann M, Kliem V, Kolch W, Krolewski AS, Luppi M, Massy Z, Melter M, Neusüss C, Novak J, Peter K, Rossing K, Rupprecht H, Schanstra JP, Schiffer E, Stolzenburg JU, Tarnow L, Theodorescu D, Thongboonkerd V, Vanholder R, Weissinger EM, Mischak H, Schmitt-Kopplin P.

Mol Cell Proteomics. 2010 Nov;9(11):2424-37. doi: 10.1074/mcp.M110.001917. Epub 2010 Jul 8.

34.

[Dialysis quantification: Is it accurate and can we make it simple?].

Ficheux A, Brunet P, Argilés A.

Nephrol Ther. 2010 Nov;6(6):491-3. doi: 10.1016/j.nephro.2010.01.009. Epub 2010 Jun 8. French. No abstract available.

PMID:
20570585
35.

Use of spent dialysate analysis to estimate blood levels of uraemic solutes without blood sampling: urea.

Ficheux A, Gayrard N, Szwarc I, Soullier S, Bismuth-Mondolfo J, Brunet P, Servel MF, Argilés A.

Nephrol Dial Transplant. 2010 Mar;25(3):873-9. doi: 10.1093/ndt/gfp539. Epub 2009 Oct 23.

PMID:
19854847
36.

Conservative treatment of the uremic syndrome.

Vanholder R, Argilés A, Beige J, Brunet P, Drüeke TB, Fliser D, Herget-Rosenthal S, Hörl WH, Jörres A, Perna A, Rodriguez-Portillo M, Spasovski G, Stegmayr B, Stenvinkel P, Wanner C, Wiecek A, Massy ZA.

Semin Dial. 2009 Jul-Aug;22(4):449-53. doi: 10.1111/j.1525-139X.2009.00600.x. Review.

PMID:
19709000
37.

The general picture of uremia.

Almeras C, Argilés A.

Semin Dial. 2009 Jul-Aug;22(4):329-33. doi: 10.1111/j.1525-139X.2009.00575.x. Review.

PMID:
19708976
38.

The role of EUTox in uremic toxin research.

Vanholder R, Abou-Deif O, Argiles A, Baurmeister U, Beige J, Brouckaert P, Brunet P, Cohen G, De Deyn PP, Drüeke TB, Fliser D, Glorieux G, Herget-Rosenthal S, Hörl WH, Jankowski J, Jörres A, Massy ZA, Mischak H, Perna AF, Rodriguez-Portillo JM, Spasovski G, Stegmayr BG, Stenvinkel P, Thornalley PJ, Wanner C, Wiecek A.

Semin Dial. 2009 Jul-Aug;22(4):323-8. doi: 10.1111/j.1525-139X.2009.00574.x.

PMID:
19708975
39.

Levels of circulating endothelial progenitor cells are related to uremic toxins and vascular injury in hemodialysis patients.

Jourde-Chiche N, Dou L, Sabatier F, Calaf R, Cerini C, Robert S, Camoin-Jau L, Charpiot P, Argiles A, Dignat-George F, Brunet P.

J Thromb Haemost. 2009 Sep;7(9):1576-84. doi: 10.1111/j.1538-7836.2009.03540.x. Epub 2009 Jul 6.

40.

Chronic kidney disease-related mineral and bone disorders.

Argilés A, Vanholder R.

Nephron Clin Pract. 2009;112(3):c128-36. doi: 10.1159/000214207. Epub 2009 Apr 24. Review.

41.

Post-conditioning to reduce renal ischaemia/reperfusion injury.

Szwarc I, Mourad G, Argiles A.

Nephrol Dial Transplant. 2009 Jul;24(7):2288-9; author reply 2289-90. doi: 10.1093/ndt/gfn663. Epub 2009 Apr 1. No abstract available.

PMID:
19339341
42.

The use of online clearances in dialysis.

Argilés A, Ficheux A.

Kidney Int. 2008 Sep;74(6):829; author reply 829-30. doi: 10.1038/ki.2008.273. No abstract available.

43.

Cytogenetic studies of 24 renal epithelial tumors with von Hippel-Lindau and fragile histidine triad protein expression correlation.

Gayrard N, Cacheux V, Iborra F, Mourad G, Argilés A.

Arch Pathol Lab Med. 2008 Jun;132(6):965-73. doi: 10.1043/1543-2165(2008)132[965:CSORET]2.0.CO;2.

PMID:
18517280
44.

Ischemic postconditioning prevents ischemic acute renal failure.

Szwarc I, Soullier S, Gayrard N, Mejean C, Mourad G, Argiles A.

Transplant Proc. 2007 Oct;39(8):2554-6.

PMID:
17954171
45.

Review on uraemic toxins III: recommendations for handling uraemic retention solutes in vitro--towards a standardized approach for research on uraemia.

Cohen G, Glorieux G, Thornalley P, Schepers E, Meert N, Jankowski J, Jankowski V, Argiles A, Anderstam B, Brunet P, Cerini C, Dou L, Deppisch R, Marescau B, Massy Z, Perna A, Raupachova J, Rodriguez M, Stegmayr B, Vanholder R, Hörl WH; European Uremic Toxin Work Group (EUTox).

Nephrol Dial Transplant. 2007 Dec;22(12):3381-90. Epub 2007 Aug 27. Review. No abstract available. Erratum in: Nephrol Dial Transplant. 2008 Feb;23(2):780.

PMID:
17724037
46.

Inconsistency of reported uremic toxin concentrations.

Meert N, Schepers E, De Smet R, Argiles A, Cohen G, Deppisch R, Drüeke T, Massy Z, Spasovski G, Stegmayr B, Zidek W, Jankowski J, Vanholder R.

Artif Organs. 2007 Aug;31(8):600-11. Review.

PMID:
17651115
47.

Review on uraemic solutes II--variability in reported concentrations: causes and consequences.

Vanholder R, Meert N, Schepers E, Glorieux G, Argiles A, Brunet P, Cohen G, Drüeke T, Mischak H, Spasovski G, Massy Z, Jankowski J; European Uremic Toxin Work Group (EUTox).

Nephrol Dial Transplant. 2007 Nov;22(11):3115-21. Epub 2007 Jun 5. Review.

PMID:
17550927
48.

Advances in urinary proteome analysis and biomarker discovery.

Fliser D, Novak J, Thongboonkerd V, Argilés A, Jankowski V, Girolami MA, Jankowski J, Mischak H.

J Am Soc Nephrol. 2007 Apr;18(4):1057-71. Epub 2007 Feb 28. Review.

49.

Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism.

Szwarc I, Argilés A, Garrigue V, Delmas S, Chong G, Deleuze S, Mourad G.

Transplantation. 2006 Sep 15;82(5):675-80.

PMID:
16969292
50.

[Molecular mechanisms involved in kidney ischemia-reperfusion].

Soullier S, Gayrard N, Méjean C, Swarcz I, Mourad G, Argilés A.

Nephrol Ther. 2005 Nov;1(5):315-21. Epub 2005 Aug 31. Review. French.

PMID:
16895701

Supplemental Content

Loading ...
Support Center